ArticleCancer chemotherapy and pharmacology2017

Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.

Allen Lee Cohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.